| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Australia | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Roizman Keith | 14 |
| #2 | Rudolf Martin | 11 |
| #3 | De Cogan Felicity Jane | 3 |
| #4 | Requard Iii John Jacob | 2 |
| #5 | Logan Ann | 1 |
| #6 | Scott Robert | 1 |
| #7 | Peacock Anna Frances Acushla | 1 |
| #8 | Hill Lisa Jayne | 1 |
| #9 | Stamboulis Artemis | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2018302022A1 | Topical delivery of therapeutic agents comprising cell-penetrating peptides for use for the treatment of age-related macular degeneration and other eye diseases | |
| US2018296525A1 | Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agents | |
| WO2018139991A1 | Treatment of age-related degeneration and other eye diseases with apolipoprotein mimetics | |
| US2018207233A1 | Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics |